
Gustavo A. Rosario Benitez
Examiner (ID: 599, Phone: (571)270-7888 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2838 |
| Total Applications | 811 |
| Issued Applications | 625 |
| Pending Applications | 91 |
| Abandoned Applications | 129 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 278118
[patent_doc_number] => 07557194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-07
[patent_title] => 'Antibody materials for an IBD-associated polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/835914
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 14611
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/557/07557194.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835914
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835914 | Antibody materials for an IBD-associated polypeptide | Apr 29, 2004 | Issued |
Array
(
[id] => 7110586
[patent_doc_number] => 20050208041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)'
[patent_app_type] => utility
[patent_app_number] => 10/831459
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20688
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831459
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831459 | Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) | Apr 22, 2004 | Issued |
Array
(
[id] => 4517818
[patent_doc_number] => 07939076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist'
[patent_app_type] => utility
[patent_app_number] => 10/831432
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 47
[patent_no_of_words] => 13219
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939076.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831432 | Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist | Apr 22, 2004 | Issued |
Array
(
[id] => 7060574
[patent_doc_number] => 20050002934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Recombinant IL-9 antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/823253
[patent_app_country] => US
[patent_app_date] => 2004-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 103138
[patent_no_of_claims] => 110
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002934.pdf
[firstpage_image] =>[orig_patent_app_number] => 10823253
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/823253 | Recombinant IL-9 antibodies | Apr 11, 2004 | Issued |
Array
(
[id] => 5857889
[patent_doc_number] => 20060228351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor'
[patent_app_type] => utility
[patent_app_number] => 10/551462
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13508
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551462
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551462 | Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor | Mar 30, 2004 | Abandoned |
Array
(
[id] => 6957895
[patent_doc_number] => 20050214265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Method for improving bone marrow engraftment'
[patent_app_type] => utility
[patent_app_number] => 10/808205
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8535
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214265.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808205 | Method for improving bone marrow engraftment | Mar 23, 2004 | Abandoned |
Array
(
[id] => 5649021
[patent_doc_number] => 20060134756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Anti-IL-20 antibodies and binding partners and methods of using in inflammation'
[patent_app_type] => utility
[patent_app_number] => 10/807997
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81320
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134756.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807997
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807997 | Anti-IL-20 antibodies and binding partners and methods of using in inflammation | Mar 23, 2004 | Abandoned |
Array
(
[id] => 7285845
[patent_doc_number] => 20040146508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Use of cd25 binding molecules in steroid-resistant patients'
[patent_app_type] => new
[patent_app_number] => 10/474071
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6928
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146508.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474071 | Use of cd25 binding molecules in steroid-resistant patients | Mar 17, 2004 | Abandoned |
Array
(
[id] => 6906168
[patent_doc_number] => 20050101563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Method and compositions for the treatment and prevention of pain and inflammation'
[patent_app_type] => utility
[patent_app_number] => 10/783160
[patent_app_country] => US
[patent_app_date] => 2004-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42963
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783160 | Method and compositions for the treatment and prevention of pain and inflammation | Feb 18, 2004 | Abandoned |
Array
(
[id] => 7111130
[patent_doc_number] => 20050208585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Agonist antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/778394
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33187
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208585.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778394 | Agonist antibodies | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7033578
[patent_doc_number] => 20050032087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Novel receptor-type phosphotyrosine phosphatase-alpha'
[patent_app_type] => utility
[patent_app_number] => 10/777144
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18597
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777144
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777144 | Novel receptor-type phosphotyrosine phosphatase-alpha | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7038868
[patent_doc_number] => 20050158302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Methods for diagnosing and treating autoimmune disease'
[patent_app_type] => utility
[patent_app_number] => 10/775487
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 40299
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10775487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/775487 | Methods for diagnosing and treating autoimmune disease | Feb 9, 2004 | Abandoned |
Array
(
[id] => 7371962
[patent_doc_number] => 20040219145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Compositions and methods to modulate immune and inflammatory responses'
[patent_app_type] => new
[patent_app_number] => 10/774708
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6711
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219145.pdf
[firstpage_image] =>[orig_patent_app_number] => 10774708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/774708 | Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody | Feb 8, 2004 | Issued |
Array
(
[id] => 7372001
[patent_doc_number] => 20040219150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Uses of mammalian cytokine; related reagents'
[patent_app_type] => new
[patent_app_number] => 10/773083
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19777
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773083
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773083 | Uses of mammalian cytokine; related reagents | Feb 3, 2004 | Abandoned |
Array
(
[id] => 7060569
[patent_doc_number] => 20050002929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Immune regulation based on the targeting of early activation molecules'
[patent_app_type] => utility
[patent_app_number] => 10/770639
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 49207
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10770639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/770639 | Immune regulation based on the depletion of CD69+ cells | Feb 1, 2004 | Issued |
Array
(
[id] => 7308751
[patent_doc_number] => 20040142389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Antibodies to peptides that target GIT transport receptors and related methods'
[patent_app_type] => new
[patent_app_number] => 10/751699
[patent_app_country] => US
[patent_app_date] => 2004-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2938
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10751699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/751699 | Antibodies to peptides that target GIT transport receptors and related methods | Jan 4, 2004 | Abandoned |
Array
(
[id] => 7322370
[patent_doc_number] => 20040136994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Methods of using CR3 and CR4 ligands for inhibiting interleukin-12 to treat autoimmune disease'
[patent_app_type] => new
[patent_app_number] => 10/744659
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10845
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20040136994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10744659
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/744659 | Methods of using CR3 and CR4 ligands for inhibiting interleukin-12 to treat autoimmune disease | Dec 22, 2003 | Abandoned |
Array
(
[id] => 7206352
[patent_doc_number] => 20040087485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Educated nkt cells and their uses in the treatment of immune-related disorders'
[patent_app_type] => new
[patent_app_number] => 10/451811
[patent_app_country] => US
[patent_app_date] => 2003-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21115
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451811
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451811 | Educated nkt cells and their uses in the treatment of immune-related disorders | Dec 15, 2003 | Abandoned |
Array
(
[id] => 7467882
[patent_doc_number] => 20040120935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Genetically modified yt cell line and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/476007
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1204
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20040120935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476007
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476007 | Genetically modified yt cell line and use thereof | Dec 8, 2003 | Abandoned |
Array
(
[id] => 5284415
[patent_doc_number] => 20090098090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'VITRO IMMUNIZATION'
[patent_app_type] => utility
[patent_app_number] => 10/538393
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10303
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538393
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538393 | VITRO IMMUNIZATION | Dec 8, 2003 | Abandoned |